Current Appointments & Affiliations
Assistant Professor of Surgery
·
2021 - Present
Surgical Oncology,
Surgery
Vice Chair, Opportunity and Engagement
·
2025 - Present
Surgery,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2020 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Journal Article Ann Surg Oncol · February 2026 Full text Link to item CiteContemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Journal Article Ann Surg Oncol · January 2026 BACKGROUND: De-escalation of axillary surgery for hormone receptor-positive breast cancer has gained traction, but guidelines for axillary management after neoadjuvant endocrine therapy (NET) remain ill-defined. METHODS: Female patients age ≥50 years with ... Full text Link to item CiteRadiation De-Escalation in Older Women with Early-Stage ER+/HER2- Invasive Breast Cancer.
Journal Article Ann Surg Oncol · November 23, 2025 BACKGROUND: National recommendations since 2004 have allowed for omission of post-lumpectomy radiotherapy for patients ≥70 years old with early-stage estrogen receptor positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. ... Full text Link to item CiteEducation, Training & Certifications
University of Missouri Kansas City, School of Medicine ·
1987
M.D.